NUVAXOVID COVID-19 Vaccine, Adjuvanted 5 ug/.5mL
nvx-cov2705 · INJECTION, SUSPENSION · Novavax, Inc.
NUVAXOVID COVID-19 Vaccine, Adjuvanted is a injection, suspension containing nvx-cov2705 at 5 ug/.5mL, taken intramuscular. Manufactured by Novavax, Inc..
Key Facts
- Brand Name
- NUVAXOVID COVID-19 Vaccine, Adjuvanted
- Generic Name
- nvx-cov2705
- NDC Code (Product)
80631-207- Manufacturer
- Novavax, Inc.
- Strength
- 5 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125817
- Marketing Start
- 08/27/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is NUVAXOVID COVID-19 Vaccine, Adjuvanted used for?
NUVAXOVID COVID-19 Vaccine, Adjuvanted contains nvx-cov2705. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is NUVAXOVID COVID-19 Vaccine, Adjuvanted a controlled substance?
NUVAXOVID COVID-19 Vaccine, Adjuvanted is not classified as a controlled substance by the DEA.
What is the generic name for NUVAXOVID COVID-19 Vaccine, Adjuvanted?
The generic name for NUVAXOVID COVID-19 Vaccine, Adjuvanted is nvx-cov2705. There are no other listed brand versions of nvx-cov2705.
What is the NDC code for NUVAXOVID COVID-19 Vaccine, Adjuvanted 5 ug/.5mL?
The NDC (National Drug Code) for NUVAXOVID COVID-19 Vaccine, Adjuvanted 5 ug/.5mL is 80631-207, listed by Novavax, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)